Protalix BioTherapeutics Inc (PLX)
1.18
-0.03
(-2.48%)
USD |
NYAM |
Apr 25, 16:00
1.20
+0.02
(+1.69%)
After-Hours: 20:00
Protalix BioTherapeutics Gross Profit (TTM): 42.51M for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 42.51M |
September 30, 2023 | 47.10M |
June 30, 2023 | 48.76M |
March 31, 2023 | 24.50M |
December 31, 2022 | 28.05M |
September 30, 2022 | 27.23M |
June 30, 2022 | 28.47M |
March 31, 2022 | 25.50M |
December 31, 2021 | 22.00M |
September 30, 2021 | 33.34M |
June 30, 2021 | 32.91M |
March 31, 2021 | 40.36M |
December 31, 2020 | 52.02M |
September 30, 2020 | 50.09M |
June 30, 2020 | 53.21M |
March 31, 2020 | 53.62M |
December 31, 2019 | 43.80M |
September 30, 2019 | 37.06M |
June 30, 2019 | 36.44M |
March 31, 2019 | 29.54M |
December 31, 2018 | 24.94M |
September 30, 2018 | 19.61M |
June 30, 2018 | 10.66M |
March 31, 2018 | 8.836M |
December 31, 2017 | 5.847M |
Date | Value |
---|---|
September 30, 2017 | 3.225M |
June 30, 2017 | 2.187M |
March 31, 2017 | 1.446M |
December 31, 2016 | 0.801M |
September 30, 2016 | 0.672M |
June 30, 2016 | 1.363M |
March 31, 2016 | 2.38M |
December 31, 2015 | 3.634M |
September 30, 2015 | 0.227M |
June 30, 2015 | 1.023M |
March 31, 2015 | 0.993M |
December 31, 2014 | 2.893M |
September 30, 2014 | -0.215M |
June 30, 2014 | -0.352M |
March 31, 2014 | 0.313M |
December 31, 2013 | 0.00 |
September 30, 2013 | 5.385M |
June 30, 2013 | 6.636M |
March 31, 2013 | 26.87M |
December 31, 2012 | 26.28M |
September 30, 2012 | 27.70M |
June 30, 2012 | 25.36M |
March 31, 2012 | -1.371M |
December 31, 2011 | 1.443M |
September 30, 2011 | 4.431M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
22.00M
Minimum
Dec 2021
53.62M
Maximum
Mar 2020
38.26M
Average
37.06M
Median
Sep 2019
Gross Profit (TTM) Benchmarks
Agenus Inc | -81.37M |
InfuSystems Holdings Inc | 63.11M |
Corbus Pharmaceuticals Holdings Inc | -- |
AIM ImmunoTech Inc | 0.16M |
Armata Pharmaceuticals Inc | -- |